Rebecca Hartley

Dr. Rebecca Hartley

Department of Cell Biology and Physiology; MSC08-4750; University of New Mexico; Albuquerque, NM 87131, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in RNA Biology
Verified
Journal Article
Closed access
XGXun Guo
Xun Guo
YWYuehan Wu
Yuehan Wu
RHRebecca Hartley
Rebecca Hartley
MicroRNAs (miRNAs) are a class of naturally occurring, small, non-coding RNAs that control gene expression during development, normal cell function, and disease. Although there is emerging evidence...

11 January 2018 in WIREs RNA
Verified
Journal Article
Closed access
PDF file
DLDaniel A. Lujan
Daniel A. Lujan
JOJoey L. Ochoa
Joey L. Ochoa
RHRebecca Hartley
Rebecca Hartley

15 August 2006 in Cancer Research
Verified
Journal Article
Open access
PDF file
XGXun Guo
Xun Guo
RHRebecca Hartley
Rebecca Hartley
Many cancers overexpress cyclin E1 and its tumor-specific low molecular weight (LMW) isoforms. However, the mechanism of cyclin E1 deregulation in cancers is still not well understood. We show here that the mRNA-binding protein HuR increases cyclin E1 mRNA stability in MCF-7 breast carcinoma cells. Thus, mRNA stabilization may be a key event in the deregulation of cyclin E1 in MCF-7 cells. Compared with MCF10A immortalized breast epithelial cells, MCF-7 cells overexpress full-length cyclin E1 and its LMW isoforms and exhibit increased cyclin E1 mRNA stability. Increased mRNA stability is associated with a stable adenylation state and an increased ratio of cytoplasmic versus nuclear HuR. UV cross-link competition and UV cross-link immunoprecipitation assays verified that HuR specifically bound to the cyclin E1 3′-untranslated region. Knockdown of HuR with small interfering RNA (siRNA) in MCF-7 cells decreased cyclin E1 mRNA half-life (t1/2) and its protein level: a 22% decrease for the full-length isoforms and 80% decrease for the LMW isoforms. HuR siRNA also delayed G1-S phase transition and inhibited MCF-7 cell proliferation, which was partially recovered by overexpression of a LMW isoform of cyclin E1. Overexpression of HuR in MCF10A cells increased cyclin E1 mRNA t1/2 and its protein level. Taken together, our data show that HuR critically contributes to cyclin E1 overexpression and its growth-promoting function, at least in part by increasing cyclin E1 mRNA stability, which provides a new mechanism of cyclin E1 deregulation in breast cancer. (Cancer Res 2006; 66(16): 7948-56)

23 September 2009 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
PDF file
XGXun Guo
Xun Guo
YWYuehan Wu
Yuehan Wu
RHRebecca Hartley
Rebecca Hartley

Verified
Journal Article
Open access
PDF file
XGXun Guo
Xun Guo
MCMelanie C. Connick
Melanie C. Connick
JVJennifer Vanderhoof
Jennifer Vanderhoof
MIMohammad-Ali Ishak
Mohammad-Ali Ishak
RHRebecca Hartley
Rebecca Hartley
RNA binding protein (RBPs) and microRNAs (miRNAs or miRs) are post-transcriptional regulators of gene expression that are implicated in development of cancers. Although their individual roles have been studied, the crosstalk between RBPs and miRNAs is under intense investigation. Here, we show that in breast cancer cells, cyclin E1 upregulation by the RBP HuR is through specific binding to regions in the cyclin E1 mRNA 3' untranslated region (3'UTR) containing U-rich elements. Similarly, miR-16 represses cyclin E1, dependent on its cognate binding sites in the cyclin E1 3'UTR. Evidence in the literature indicates that HuR can regulate miRNA expression and recruit or dissociate RNA-induced silencing complexes (RISC). Despite this, miR-16 and HuR do not affect the other’s expression level or binding to the cyclin E1 3'UTR. While HuR overexpression partially blocks miR-16 repression of a reporter mRNA containing the cyclin E1 3'UTR, it does not block miR-16 repression of endogenous cyclin E1 mRNA. In contrast, miR-16 blocks HuR-mediated upregulation of cyclin E1. Overall our results suggest that miR-16 can override HuR upregulation of cyclin E1 without affecting HuR expression or association with the cyclin E1 mRNA.

4 July 2010 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
YWYuehan Wu
Yuehan Wu
XGXun Guo
Xun Guo
YBYekaterina Brandt
Yekaterina Brandt
HHHelen J. Hathaway
Helen J. Hathaway
RHRebecca Hartley
Rebecca Hartley